Multitumor | PARP Inhibition in Four Common Cancers: Biology, Clinical Research Database and Therapeutic Strategy

Faculty presentations from a CME symposium held at the 2019 AACR Annual Meeting. Long description: Faculty presentations from a CME symposium held at the 2019 AACR Annual Meeting. Featuring perspectives from Drs Emmanuel S Antonarakis, Kathleen Moore, Michael J Pishvaian and Melinda Telli. PARP Inhibition as a Therapeutic Strategy — Ovarian Cancer at the Vanguard — Dr Moore (00:00) Current and Emerging Role of PARP Inhibitors in Metastatic Breast Cancer — Dr Telli (8:45) Pancreatic Cancer and PARP Inhibition — What We Know and What We Don’t — Dr Pishvaian (20:45) DNA Repair Deficiency in Advanced Prostate Cancer and the Potential Role of PARP Inhibition — Dr Antonarakis (30:18) Select publications